Comparative Mortality Risk in Adult Patients With Schizophrenia, Depression, Bipolar Disorder, Anxiety Disorders, and Attention-Deficit/Hyperactivity Disorder Participating in Psychopharmacology Clinical Trials
JAMA Psychiatry - United States
doi 10.1001/jamapsychiatry.2013.149
Full Text
Open PDFAbstract
Available in full text
Date
October 1, 2013
Authors
Publisher
American Medical Association (AMA)